Chen, Aiqi. “CD19 And CD22 Dual-Target CAR-T Therapy Via CRISPR Cas9 Engineering for Relapsed B-Cell Acute Lymphoblastic Leukemia”. Academic Journal of Science and Technology 18, no. 1 (December 28, 2025): 621–625. Accessed July 7, 2026. https://drpress.org/ojs/index.php/ajst/article/view/33145.